New Weight-Loss shot shows promise in early trial
Disease control
Completed
This early-stage study tested a new drug called TE-8105 in 38 overweight or obese adults who do not have diabetes. The main goal was to check if the drug is safe and to see how it affects body weight. Participants received one or more doses of the drug, and researchers monitored …
Phase: PHASE1, PHASE2 • Sponsor: Immunwork, Inc. • Aim: Disease control
Last updated May 09, 2026 11:39 UTC